Search Videos and More
E3 ubiquitin ligase Herc3 deficiency leads to accumulation of subretinal microglia and retinal neurodegeneration
Vision depends on the delicate orchestration of many complex processes in the retina.SELECTing Treatments for Cardiovascular Disease — Obesity in the Spotlight
Amit Khera, M.D., Director of UT Southwestern’s Preventive Cardiology Program, co-authored a widely circulated editorial in the New England Journal of Medicine that captured the impact of the SELECT trial, which made headlines in November at the annual AHA Scientific Sessions conference.Experimental compound extends life in ALS mouse model
Molecule discovered by UTSW researchers could lead to new therapies for devastating motor neuron diseaseThe Target | Department of Radiation Oncology - Winter 2023
The Department of Radiation Oncology at UT Southwestern continues to blaze forward in all aspects of cancer care, including several highlights featured in this issue.Wendy and Emery Reves International Breast Cancer Symposium
Friday, May 3, 2024 | T. Boone Pickens Biomedical Building at UT Southwestern Medical CenterMiguel’s story: Seeing the world, thanks to an innovative treatment
A team of doctors at Children’s Health use a state-of-the-art treatment to save a patient’s life and his vision.Neurology residents refine their observational skills by studying the arts
The famous work – Landscape with the Fall of Icarus – was highlighted during a lecture series using art to hone the observational skills of UT Southwestern medical trainees.E-scooter injuries can come at a cost to the public
Electric scooters carry a significant risk of orthopedic injuries and associated costs for medical care, which can create a financial burden for the public, according to a study by UT Southwestern Medical Center researchers.A Beacon of Hope in the Fight against Pancreatic Cancer
Picture yourself embarking on a challenging mountain climbing expedition despite having no prior experience. You’re not alone; a dedicated team of experts stands ready to assist.DARTBOARD daily adaptive radiotherapy concludes accrual with positive interim results
DARTBOARD (STU2021-0401: A Prospective Randomized Phase II Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer), an innovative, first-of-its-kind clinical trial, is now complete.Uncovering cerebellar modification
UTSW researchers discover that modulating Fmr1 gene’s activity in the brain improved behaviors in fragile X mutant modelRobotic surgery improves outcomes for most colon cancer patients
UT Southwestern study finds lower rates of complications and shorter hospital stays compared with laparoscopic techniques